Revenue

With a major new investment, Cognito Therapeutics is pushing its non-invasive light and sound therapy for Alzheimer's toward a 2027 market launch.

A new acquisition in data center alley reveals how investors are profiting from the AI boom by betting on the crucial, but overlooked, support infrastructure.

BioRestorative Therapies is leveraging its clinical-grade regenerative medicine to disrupt the aesthetics industry. Can science beat marketing?

With a 30-year operations veteran retiring, Delta promotes a new president, COO, and CFO, betting on internal talent to navigate its future growth.

A new survey finds AI makes procurement teams 3.7x more resilient, yet many leaders are held back by a dangerous overconfidence in their own knowledge.

Asia's top tech expo unveils its 2026 theme, focusing on AI's leap from code to robotics, wearables, and smart systems, cementing the region's global role.

Tabia Health's AI platform is now a qualified solution on Mayo Clinic Platform, a move set to automate patient care and reduce clinician burden.

As burnout plagues radiology, Fujifilm unveils AI workflow solutions at HIMSS 2026 aimed at easing workloads and boosting hospital efficiency.

A new survey reveals over half of Americans delay healthcare, creating a 'health debt' crisis fueled by cost fears and scheduling conflicts for younger generations.

A new partnership between Always and The Fibroid Foundation aims to break the silence on heavy periods and fibroids, combining product innovation with advocacy.

With book value soaring, Stack Capital offers a rare public window into the massive valuations of private titans like SpaceX and the AI infrastructure boom.

Starton Therapeutics files patents to combine its continuous low-dose therapy, STAR-LLD, with CAR-T, aiming to enhance cancer-killing power and durability.

Taiwanese biotech GNTbm's oral drug GNTbm-38, which turns 'cold' tumors 'hot', will begin Phase 1 trials for advanced and refractory cancers.

AI firm YXT.com lands on a top innovation list with tech giants, but can its cutting-edge training solutions navigate a complex market and redefine work?

Iconic Australian bootmaker R.M.Williams expands its partnership with Bamboo Rose, leveraging AI-powered planning to modernize its global operations.

A new partnership sees Veritone's AI unlock The Washington Post's video vault, aiming to monetize history while protecting journalistic integrity.

Spirent's new SimXTRACT tool promises to slash PNT development time by bringing real-world satellite signal complexity into the controlled lab environment.

AI drug discovery firm Proxima appoints three titans of science to its board, signaling a major push in proximity therapeutics to rewrite medicine's rules.

A new report reveals why distributors are holding more stock, risking cash flow to battle volatility and win customers in a fiercely competitive market.

With FDA Breakthrough status for its MASH drug, a new CEO, and a fortified balance sheet, Altimmune is poised to take on serious liver disease and addiction.